·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊ½ºÅ¸Å¬·´TVÆÊµµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ ÆÄ¸¶¸®¼Ä¡¹ÙÀÌ¿À '1õ¸¸ºÒ ¼öÃâÀÇ Å¾' ¼ö»ó ±â»çÀÔ·Â : 23.12.15 08:26:34 0 °¡ ÇÃÄ£Ãß°¡ Áö¼ÓÀûÀÎ ¼öÃâ Áõ°¡¡¦º¸Åø¸®´®Åå½Å Àü¹®±â¾÷ ¼ºÀå AD 11¿ù 2ÁÖÂ÷ ¸ÅÃ⠺м®ÀÌ ÇÊ¿äÇϸé? BRPInsight [µ¥Àϸ®ÆÊ=À̼®ÁØ ±âÀÚ] ÆÄ¸¶¸®¼Ä¡ÀÇ Åå½ÅºÎ¹® ÀÚȸ»ç ÆÄ¸¶¸®¼Ä¡¹ÙÀÌ¿À(´ëÇ¥ ¹é½Â°É, ¿øÄ¡¿±)´Â Áö³ 14ÀÏ Ãáõ ¼¼Á¾È£ÅÚ¿¡¼ ¿¸° Á¦60ȸ ¹«¿ªÀdz¯ ¹× Á¦7ȸ °¿ø ¼öÃâÀÎÀÇ ³¯ Çà»ç¿¡¼ '1õ¸¸ºÒ ¼öÃâÀÇ Å¾'À» ¼ö»óÇß´Ù°í 15ÀÏ ¹àÇû´Ù. 2019³â º¸Åø¸®´® Åå½Å ¸®¿£Å彺·Î ÇØ¿Ü ù ¼öÃâÀ» ½ÃÀÛÇÑ ÆÄ¸¶¸®¼Ä¡¹ÙÀÌ¿À´Â Äڷγª ÆÒµ¥¹Í°ú ±¹³»¿Ü °æÁ¦ À§±â¿¡µµ ºÒ±¸ÇÏ°í ¿¬Æò±Õ 70% ÀÌ»óÀÇ ³ôÀº ¸ÅÃâ ½ÅÀå·üÀ» ±â·ÏÇß´Ù. ÃÖ±Ù¿¡´Â Áö¼ÓÀûÀÎ ¼öÃâ Áõ°¡¿¡ ´ëÀÀÇϰíÀÚ °¸ª°úÇлê¾÷´ÜÁö¿¡ Á¦2°øÀå Âø°ø½Äµµ °³ÃÖÇß´Ù. ÆÄ¸¶¸®¼Ä¡¹ÙÀÌ¿À °ü°èÀÚ´Â "´ë³»¿Ü ¾î·Á¿î ȯ°æ ¼Ó¿¡¼µµ ±¹°¡ ¼öÃâ ½ÇÀû¿¡ ±â¿©ÇØ ¶æ ±í´Ù. ¾ÕÀ¸·Îµµ ±Û·Î¹ú º¸Åø¸®´®Åå½Å Àü¹®±â¾÷À¸·Î ¼ºÀåÇϱâ À§ÇØ ´õ¿í ´õ ³ë·ÂÇØ ³ª°¡°Ú´Ù"°í ¸»Çß´Ù. ÇÑÆí, ÆÄ¸¶¸®¼Ä¡¹ÙÀÌ¿À´Â º¸Åø¸®´® Åå½Å ¸®¿£Å彺ÁÖ 100´ÜÀ§, 200´ÜÀ§ Á¦Ç°À» »ý»ê, ÇØ¿Ü ¼öÃâÇϰí ÀÖ´Ù. X AD µðÅ×ÀÏÆäÀÌÆÛ ¹Þ±â À̺¥Æ®Âü¿© ¡æ À̼®ÁØ ±âÀÚ(wiviwivi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç BD¶óÀ̼¾½ÌÆÀ °ü¸®ÀÚ/ÆÀÀå, °æ·Â»ç¿ø ¹× Àü¹®¿¬±¸¿ä¿ø ¸ðÁý ¹Ù·Î°¡±â JW 2025³â 5Â÷ ¼ö½Ãä¿ë ¹Ù·Î°¡±â Á¦¾à ¸¶ÄÉÆÃ ¾à»ç ¹Ù·Î°¡±â [´ë¿õÁ¦¾à] 2026 »ó¡¤ÇϹݱ⠾à´ë½ÉȽǽÀ ¸ðÁý ¹Ù·Î°¡±â 2025³â Á¦5Â÷ Á÷¿øÃ¤¿ë °ø°í ¹Ù·Î°¡±â Clinical Research Associate (CRA) ¹Ù·Î°¡±â Á¦Á¦¿¬±¸´ã´ç °æ·Â 5³â¡è(°ú~Â÷Àå±Þ) ä¿ë ¹Ù·Î°¡±â Çâ³²°øÀå OQA ǰÁú°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â °æ·Â Á¦¾à ÇØ¿Ü¸¶ÄÉÆÃ (ÀÎÇã°¡ ´ã´ç) ä¿ë ¹Ù·Î°¡±â ȯÀÎÁ¦¾à(ÁÖ) 11¿ù ¼ö½Ãä¿ë(11/30(ÀÏ) 23:59±îÁö) ¹Ù·Î°¡±â Regulatory Execution Hub Sr. Associate ¹Ù·Î°¡±â °³¹ßº»ºÎ ±âȹ, RA ÆÀÀå±Þ ä¿ë(°æ·Â 10³â¡è) ¹Ù·Î°¡±â [Çѱ¹¿ÀÃ÷Ä«Á¦¾à] Á¤±ÔÁ÷ °æ·Â CQM ä¿ë ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÆÄ¸¶¸®¼Ä¡¹ÙÀÌ¿À 1õ¸¸ºÒ ¼öÃâÀÇ Å¾ ¼ö»ó URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ÆÄ¸¶¸®¼Ä¡¹ÙÀÌ¿À '1õ¸¸ºÒ ¼öÃâÀÇ Å¾' ¼ö»ó ±â»çÀÔ·Â : 23.12.15 08:26:34 0 °¡ ÇÃÄ£Ãß°¡ Áö¼ÓÀûÀÎ ¼öÃâ Áõ°¡¡¦º¸Åø¸®´®Åå½Å Àü¹®±â¾÷ ¼ºÀå AD 11¿ù 2ÁÖÂ÷ ¸ÅÃ⠺м®ÀÌ ÇÊ¿äÇϸé? BRPInsight [µ¥Àϸ®ÆÊ=À̼®ÁØ ±âÀÚ] ÆÄ¸¶¸®¼Ä¡ÀÇ Åå½ÅºÎ¹® ÀÚȸ»ç ÆÄ¸¶¸®¼Ä¡¹ÙÀÌ¿À(´ëÇ¥ ¹é½Â°É, ¿øÄ¡¿±)´Â Áö³ 14ÀÏ Ãáõ ¼¼Á¾È£ÅÚ¿¡¼ ¿¸° Á¦60ȸ ¹«¿ªÀdz¯ ¹× Á¦7ȸ °¿ø ¼öÃâÀÎÀÇ ³¯ Çà»ç¿¡¼ '1õ¸¸ºÒ ¼öÃâÀÇ Å¾'À» ¼ö»óÇß´Ù°í 15ÀÏ ¹àÇû´Ù. 2019³â º¸Åø¸®´® Åå½Å ¸®¿£Å彺·Î ÇØ¿Ü ù ¼öÃâÀ» ½ÃÀÛÇÑ ÆÄ¸¶¸®¼Ä¡¹ÙÀÌ¿À´Â Äڷγª ÆÒµ¥¹Í°ú ±¹³»¿Ü °æÁ¦ À§±â¿¡µµ ºÒ±¸ÇÏ°í ¿¬Æò±Õ 70% ÀÌ»óÀÇ ³ôÀº ¸ÅÃâ ½ÅÀå·üÀ» ±â·ÏÇß´Ù. ÃÖ±Ù¿¡´Â Áö¼ÓÀûÀÎ ¼öÃâ Áõ°¡¿¡ ´ëÀÀÇϰíÀÚ °¸ª°úÇлê¾÷´ÜÁö¿¡ Á¦2°øÀå Âø°ø½Äµµ °³ÃÖÇß´Ù. ÆÄ¸¶¸®¼Ä¡¹ÙÀÌ¿À °ü°èÀÚ´Â "´ë³»¿Ü ¾î·Á¿î ȯ°æ ¼Ó¿¡¼µµ ±¹°¡ ¼öÃâ ½ÇÀû¿¡ ±â¿©ÇØ ¶æ ±í´Ù. ¾ÕÀ¸·Îµµ ±Û·Î¹ú º¸Åø¸®´®Åå½Å Àü¹®±â¾÷À¸·Î ¼ºÀåÇϱâ À§ÇØ ´õ¿í ´õ ³ë·ÂÇØ ³ª°¡°Ú´Ù"°í ¸»Çß´Ù. ÇÑÆí, ÆÄ¸¶¸®¼Ä¡¹ÙÀÌ¿À´Â º¸Åø¸®´® Åå½Å ¸®¿£Å彺ÁÖ 100´ÜÀ§, 200´ÜÀ§ Á¦Ç°À» »ý»ê, ÇØ¿Ü ¼öÃâÇϰí ÀÖ´Ù. X AD µðÅ×ÀÏÆäÀÌÆÛ ¹Þ±â À̺¥Æ®Âü¿© ¡æ À̼®ÁØ ±âÀÚ(wiviwivi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç BD¶óÀ̼¾½ÌÆÀ °ü¸®ÀÚ/ÆÀÀå, °æ·Â»ç¿ø ¹× Àü¹®¿¬±¸¿ä¿ø ¸ðÁý ¹Ù·Î°¡±â JW 2025³â 5Â÷ ¼ö½Ãä¿ë ¹Ù·Î°¡±â Á¦¾à ¸¶ÄÉÆÃ ¾à»ç ¹Ù·Î°¡±â [´ë¿õÁ¦¾à] 2026 »ó¡¤ÇϹݱ⠾à´ë½ÉȽǽÀ ¸ðÁý ¹Ù·Î°¡±â 2025³â Á¦5Â÷ Á÷¿øÃ¤¿ë °ø°í ¹Ù·Î°¡±â Clinical Research Associate (CRA) ¹Ù·Î°¡±â Á¦Á¦¿¬±¸´ã´ç °æ·Â 5³â¡è(°ú~Â÷Àå±Þ) ä¿ë ¹Ù·Î°¡±â Çâ³²°øÀå OQA ǰÁú°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â °æ·Â Á¦¾à ÇØ¿Ü¸¶ÄÉÆÃ (ÀÎÇã°¡ ´ã´ç) ä¿ë ¹Ù·Î°¡±â ȯÀÎÁ¦¾à(ÁÖ) 11¿ù ¼ö½Ãä¿ë(11/30(ÀÏ) 23:59±îÁö) ¹Ù·Î°¡±â Regulatory Execution Hub Sr. Associate ¹Ù·Î°¡±â °³¹ßº»ºÎ ±âȹ, RA ÆÀÀå±Þ ä¿ë(°æ·Â 10³â¡è) ¹Ù·Î°¡±â [Çѱ¹¿ÀÃ÷Ä«Á¦¾à] Á¤±ÔÁ÷ °æ·Â CQM ä¿ë ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÆÄ¸¶¸®¼Ä¡¹ÙÀÌ¿À 1õ¸¸ºÒ ¼öÃâÀÇ Å¾ ¼ö»ó URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ÆÄ¸¶¸®¼Ä¡¹ÙÀÌ¿À '1õ¸¸ºÒ ¼öÃâÀÇ Å¾' ¼ö»ó ±â»çÀÔ·Â : 23.12.15 08:26:34 0 °¡ ÇÃÄ£Ãß°¡ Áö¼ÓÀûÀÎ ¼öÃâ Áõ°¡¡¦º¸Åø¸®´®Åå½Å Àü¹®±â¾÷ ¼ºÀå AD 11¿ù 2ÁÖÂ÷ ¸ÅÃ⠺м®ÀÌ ÇÊ¿äÇϸé? BRPInsight [µ¥Àϸ®ÆÊ=À̼®ÁØ ±âÀÚ] ÆÄ¸¶¸®¼Ä¡ÀÇ Åå½ÅºÎ¹® ÀÚȸ»ç ÆÄ¸¶¸®¼Ä¡¹ÙÀÌ¿À(´ëÇ¥ ¹é½Â°É, ¿øÄ¡¿±)´Â Áö³ 14ÀÏ Ãáõ ¼¼Á¾È£ÅÚ¿¡¼ ¿¸° Á¦60ȸ ¹«¿ªÀdz¯ ¹× Á¦7ȸ °¿ø ¼öÃâÀÎÀÇ ³¯ Çà»ç¿¡¼ '1õ¸¸ºÒ ¼öÃâÀÇ Å¾'À» ¼ö»óÇß´Ù°í 15ÀÏ ¹àÇû´Ù. 2019³â º¸Åø¸®´® Åå½Å ¸®¿£Å彺·Î ÇØ¿Ü ù ¼öÃâÀ» ½ÃÀÛÇÑ ÆÄ¸¶¸®¼Ä¡¹ÙÀÌ¿À´Â Äڷγª ÆÒµ¥¹Í°ú ±¹³»¿Ü °æÁ¦ À§±â¿¡µµ ºÒ±¸ÇÏ°í ¿¬Æò±Õ 70% ÀÌ»óÀÇ ³ôÀº ¸ÅÃâ ½ÅÀå·üÀ» ±â·ÏÇß´Ù. ÃÖ±Ù¿¡´Â Áö¼ÓÀûÀÎ ¼öÃâ Áõ°¡¿¡ ´ëÀÀÇϰíÀÚ °¸ª°úÇлê¾÷´ÜÁö¿¡ Á¦2°øÀå Âø°ø½Äµµ °³ÃÖÇß´Ù. ÆÄ¸¶¸®¼Ä¡¹ÙÀÌ¿À °ü°èÀÚ´Â "´ë³»¿Ü ¾î·Á¿î ȯ°æ ¼Ó¿¡¼µµ ±¹°¡ ¼öÃâ ½ÇÀû¿¡ ±â¿©ÇØ ¶æ ±í´Ù. ¾ÕÀ¸·Îµµ ±Û·Î¹ú º¸Åø¸®´®Åå½Å Àü¹®±â¾÷À¸·Î ¼ºÀåÇϱâ À§ÇØ ´õ¿í ´õ ³ë·ÂÇØ ³ª°¡°Ú´Ù"°í ¸»Çß´Ù. ÇÑÆí, ÆÄ¸¶¸®¼Ä¡¹ÙÀÌ¿À´Â º¸Åø¸®´® Åå½Å ¸®¿£Å彺ÁÖ 100´ÜÀ§, 200´ÜÀ§ Á¦Ç°À» »ý»ê, ÇØ¿Ü ¼öÃâÇϰí ÀÖ´Ù. X AD µðÅ×ÀÏÆäÀÌÆÛ ¹Þ±â À̺¥Æ®Âü¿© ¡æ À̼®ÁØ ±âÀÚ(wiviwivi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÆÄ¸¶¸®¼Ä¡¹ÙÀÌ¿À 1õ¸¸ºÒ ¼öÃâÀÇ Å¾ ¼ö»ó URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö